You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 15, Issue 1

January 2008 - 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

  • Article
  • Open Access
23 Citations
1,383 Views
15 Pages

Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer

  • C.T. Kouroukis,
  • S. Chia,
  • S. Verma,
  • D. Robson,
  • C. Desbiens,
  • C. Cripps and
  • J. Mikhael

1 January 2008

Hematologic toxicities of cancer chemotherapy are common and often limit the ability to provide treatment in a timely and dose-intensive manner. These limitations may be of utmost importance in the adjuvant and curative intent settings. Hematologic t...

  • Article
  • Open Access
143 Citations
2,042 Views
12 Pages

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

  • J. R. Mackey,
  • M. Clemons,
  • M.A. Côté,
  • D. Delgado,
  • S. Dent,
  • A. Paterson,
  • L. Provencher,
  • M.B. Sawyer and
  • S. Verma

1 January 2008

Trastuzumab has been shown to be an effective therapy for women with breast cancer that overexpresses the human epidermal growth factor receptor 2 (her2) protein. In the pivotal metastatic breast cancer trials, cardiac dysfunction was observed in wom...

  • Article
  • Open Access
11 Citations
1,069 Views
6 Pages

Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma

  • N. Levesque,
  • K. Mitchinson,
  • D. Lawrie,
  • L. Fedorak,
  • D. MacDonald,
  • C. Normand and
  • J.F. Pouliot

1 January 2008

The goal of the 1-year observational, multicentre, open-label study reported here was to identify factors influencing adherence to high-dose interferon alfa-2b adjuvant therapy in patients at high risk of recurrence following surgical excision of mal...

  • Article
  • Open Access
64 Citations
1,208 Views
7 Pages

1 January 2008

Traditional Chinese Medicine (tcm) may be integrated with conventional Western medicine to enhance the care of patients with cancer. Although tcm is normally implemented as a whole system, recent reductionist research suggests mechanisms for the effe...

  • Article
  • Open Access
15 Citations
1,082 Views
5 Pages

1 January 2008

The Ontario Cancer Research Ethics Board (ocreb) has made its mark within Ontario as a successful, centralized, oncology-specific research ethics board. As such, ocreb has proven invaluable to principal investigators, sponsors, and study participants...

  • Article
  • Open Access
63 Citations
3,124 Views
10 Pages

Radiation Recall Dermatitis: Case Report and Review of the Literature

  • A. E. Hird,
  • J. Wilson,
  • S. Symons,
  • E. Sinclair,
  • M. Davis and
  • E. Chow

1 January 2008

“Radiation recall”—also called “radiation recall dermatitis”—has been defined as the “recalling” by skin of previous radiation exposure in response to the administration of certain response-inducing drugs. Although the phenomenon is relatively well k...

  • Article
  • Open Access
4 Citations
938 Views
2 Pages

1 January 2008

Crack cocaine can cause a variety of pulmonary and cardiac complications. Pulmonary findings in a 65- year-old man with non-Hodgkin lymphoma who presented with shortness of breath not resolving with antibiotics are presented here. The usual manifesta...

of 2